Khedezla
Drug - Khedezla (desvenlafaxine, extended-release)
June 2014
Therapeutic area - Antidepressant
Approval criteria
- Provider provides a compelling clinical reason why the new salt formulation will provide superior clinical efficacy than the original active ingredient and formulation AND
- Patient has tried and failed venlafaxine, 2 SSRI's, and Pristiq
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411